These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 36526567)

  • 1. Post-Approval Safety Profile of Amulet vs Watchman FLX Left Atrial Appendage Closure Devices: Analysis from the MAUDE Database (ALERT-MAUDE Study).
    Velagapudi P; Oberoi M; Turagam MK; Garg J; Nair DG; Sommer R; Lakkireddy DJ
    Cardiovasc Revasc Med; 2023 Apr; 49():66-67. PubMed ID: 36526567
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical efficacy and safety comparison of Watchman device versus ACP/Amulet device for percutaneous left atrial appendage closure in patients with nonvalvular atrial fibrillation: A study-level meta-analysis of clinical trials.
    Bing S; Chen RR
    Clin Cardiol; 2023 Feb; 46(2):117-125. PubMed ID: 36448417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinical Trial.
    Galea R; De Marco F; Meneveau N; Aminian A; Anselme F; Gräni C; Huber AT; Teiger E; Iriart X; Babongo Bosombo F; Heg D; Franzone A; Vranckx P; Fischer U; Pedrazzini G; Bedogni F; Räber L; Valgimigli M
    Circulation; 2022 Mar; 145(10):724-738. PubMed ID: 34747186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and Rationale of the Swiss-Apero Randomized Clinical Trial: Comparison of Amplatzer Amulet vs Watchman Device in Patients Undergoing Left Atrial Appendage Closure.
    Galea R; De Marco F; Aminian A; Meneveau N; Anselme F; Gräni C; Huber AT; Teiger E; Iriart X; Angelillis M; Brugger N; Spirito A; Corpataux N; Franzone A; Vranckx P; Fischer U; Pedrazzini G; Bedogni F; Windecker S; Räber L; Valgimigli M
    J Cardiovasc Transl Res; 2021 Oct; 14(5):930-940. PubMed ID: 33884564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bailout Additional Watchman FLX Device Implantation for Left Atrial Appendage Closure.
    Frazzetto M; Costa G; Scandura S; Tamburino C; Grasso C
    Cardiovasc Revasc Med; 2022 Jul; 40():208-209. PubMed ID: 35123915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety profiles of percutaneous left atrial appendage closure devices: An analysis of the Food and Drug Administration Manufacturer and User Facility Device Experience (MAUDE) database from 2009 to 2016.
    Jazayeri MA; Vuddanda V; Turagam MK; Parikh V; Lavu M; Atkins D; Earnest M; Di Biase L; Natale A; Wilber D; Reddy YM; Lakkireddy DR
    J Cardiovasc Electrophysiol; 2018 Jan; 29(1):5-13. PubMed ID: 28988455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Watchman FLX vs. Watchman 2.5 in a Dual-Center Left Atrial Appendage Closure Cohort: the WATCH-DUAL study.
    Galea R; Mahmoudi K; Gräni C; Elhadad S; Huber AT; Heg D; Siontis GCM; Brugger N; Sebag F; Windecker S; Valgimigli M; Landolff Q; Roten L; Amabile N; Räber L
    Europace; 2022 Oct; 24(9):1441-1450. PubMed ID: 35253840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved Left Atrial Appendage Closure With the New-Generation WATCHMAN FLX by Cardiac Computed Tomography Angiography at 45 Days Postimplant.
    Ranard LS; Guber K; Khalique OK; Leb J; Hamid N; Donald E; Hahn RT; Forman J; Ng V; Leon MB; Sommer R; Vahl TP
    Circ Cardiovasc Interv; 2022 Apr; 15(4):e011727. PubMed ID: 35313734
    [No Abstract]   [Full Text] [Related]  

  • 9. Post-release shift with Watchman FLX devices during left atrial appendage closure: the "popcorn effect".
    Silva I; Beaudoin J; Champagne J; Paradis JM; Bernier M; O'Connor K; Dognin N; Lemyre M; Rodés-Cabau J; O'Hara G; Salaun E
    EuroIntervention; 2022 Jun; 18(2):e181-e182. PubMed ID: 35352680
    [No Abstract]   [Full Text] [Related]  

  • 10. Short term outcome after left atrial appendage occlusion with the AMPLATZER Amulet and WATCHMAN device: results from the ORIGINAL registry (saxOnian RegIstry analyzinG and followINg left atrial Appendage cLosure).
    Kretzler L; Mues C; Wunderlich C; Langbein A; Spitzer SG; Gerk U; Schellong S; Ketteler T; Neuser H; Schwefer M; Strasser R; Ibrahim K; Schoen S; Christoph M
    BMC Cardiovasc Disord; 2022 Jun; 22(1):271. PubMed ID: 35710343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First experience with the Watchman FLX occluder for percutaneous left atrial appendage closure.
    Seeger J; Birkemeyer R; Rottbauer W; Wöhrle J
    Cardiovasc Revasc Med; 2017; 18(7):512-516. PubMed ID: 28495117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Closure of the left atrial appendage using percutaneous transcatheter occlusion devices.
    Gianni C; Anannab A; Sahore Salwan A; Della Rocca DG; Natale A; Horton RP
    J Cardiovasc Electrophysiol; 2020 Aug; 31(8):2179-2186. PubMed ID: 32249473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One year outcome and analysis of peri-device leak of left atrial appendage occlusion devices.
    Mansour MJ; Harnay E; Al Ayouby A; Mansourati V; Jobic Y; Gilard M; Le Ven F; Mansourati J
    J Interv Card Electrophysiol; 2022 Jun; 64(1):27-34. PubMed ID: 34002319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
    Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
    JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.
    Reddy VY; Doshi SK; Kar S; Gibson DN; Price MJ; Huber K; Horton RP; Buchbinder M; Neuzil P; Gordon NT; Holmes DR;
    J Am Coll Cardiol; 2017 Dec; 70(24):2964-2975. PubMed ID: 29103847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left Atrial Appendage Closure for Stroke Prevention: Devices, Techniques, and Efficacy.
    Iskandar S; Vacek J; Lavu M; Lakkireddy D
    Cardiol Clin; 2016 May; 34(2):329-51. PubMed ID: 27150181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left atrial appendage closure in patients with prohibitive anatomy: Insights from PINNACLE FLX.
    Ellis CR; Jackson GG; Kanagasundram AN; Mansour M; Sutton B; Houle VM; Kar S; Doshi S; Osorio J
    Heart Rhythm; 2021 Jul; 18(7):1153-1161. PubMed ID: 33957090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MAUDE Database Analysis of Post-Approval Outcomes following Left Atrial Appendage Closure with the Watchman Device.
    Ledesma PA; Uzomah UA; Yu X; Shaqdan A; Khaloo P; Galvin J; Mansour M; Ptaszek LM; Ruskin JN
    Am J Cardiol; 2021 Aug; 152():78-87. PubMed ID: 34116792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Body Mass Index With Outcomes in Patients Undergoing Percutaneous Left Atrial Appendage Closure With the Watchman Device.
    Minhas AMK; Gul S; Sheikh AB; Nazir S; Ahuja KR; Anwar MN; Dani SS; Goel SS; Virani SS; Alam M
    Curr Probl Cardiol; 2022 Dec; 47(12):101009. PubMed ID: 34599987
    [No Abstract]   [Full Text] [Related]  

  • 20. Percutaneous closure of a very large left atrial appendage using the Amplatzer amulet.
    Freixa X; Kwai Chan JL; Tzikas A; Garceau P; Basmadjian A; Ibrahim R
    Can J Cardiol; 2013 Oct; 29(10):1329.e9-1329.e11. PubMed ID: 23541662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.